Search Results Search Sort by RelevanceMost Recent Podcast May 2022 Author Interview: “Seven Points for Athletes to Consider Before Using a Dietary Supplement” Dr Amy B. Cadwallader joins Ethics Talk to discuss her article: “Seven Points for Athletes to Consider Before Using a Dietary Supplement.” Case and Commentary May 2022 ¿Cómo deberían responder los médicos al interés de los pacientes sobre suplementos dietético para tratar enfermedades crónicas graves? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES AMA J Ethics. 2022;E361-367. doi: 10.1001/amajethics.2022.361. Health Law May 2022 ¿La regulación de suplementos dietéticos como alimentos promueve la seguridad pública en un mundo de influentes en redes sociales? Joshua Klein and Scott J. Schweikart, JD, MBE Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary can have clinical and public health consequences. AMA J Ethics. 2022;E396-401. doi: 10.1001/amajethics.2022.396. In the Literature Oct 2002 Should Clinician-Researchers Disclose Financial Incentives to Patients? Jeremy Spevick Virtual Mentor. 2002;4(10):299-301. doi: 10.1001/virtualmentor.2002.4.10.jdsc1-0210. Viewpoint Mar 2016 Undocumented Immigrants Face a Unique Set of Risks from Tuberculosis Treatment: Is This Just? Kelly A. Kyanko, MD, MHS, Jun-Chieh James Tsay, MD, MSc, Katherine Yun, MD, MHS, and Brendan Parent, JD Undocumented immigrants treated with isoniazid (INH) for latent tuberculosis infection should be covered for transplant for INH-related liver failure. AMA J Ethics. 2016;18(3):311-318. doi: 10.1001/journalofethics.2016.18.3.sect1-1603. Case and Commentary Aug 2022 When Experiencing Inequitable Health Care Is a Patient’s Norm, How Should Iatrogenic Harm Be Considered? Bantale Ayisire, MS, RN and Kristen R. Choi, PhD, RN Inequitable care and outcomes experienced by persons with mental illness have long been exacerbated by stigma expressed by clinicians. AMA J Ethics. 2022;24(8):E729-734. doi: 10.1001/amajethics.2022.729. Case and Commentary Aug 2022 When Is Iatrogenic Harm Negligent? Ramya Sampath All harm resulting from negligence is iatrogenic, but not all iatrogenic injury is negligent. AMA J Ethics. 2022;24(8):E735-739. doi: 10.1001/amajethics.2022.735. State of the Art and Science Aug 2022 What Should Clinicians and Patients Know About the Clinical Gaze, Disability, and Iatrogenic Harm When Making Decisions? Chloë G. K. Atkins, PhD and Sunit Das, MD, PhD Avoiding harm requires that clinicians not overly rely on assumptions about “normal” embodiment. AMA J Ethics. 2022;24(8):E762-767. doi: 10.1001/amajethics.2022.762. AMA Code Says Nov 2002 AMA Code of Medical Ethics’ Serves as "Gold Standard" Audiey Kao, MD, PhD Virtual Mentor. 2002;4(11):329-330. doi: 10.1001/virtualmentor.2002.4.11.code1-0211. Medicine and Society Mar 2022 Por qué el acceso equitativo al parto vaginal requiere la eliminación de la medicina racial Nicholas Rubashkin, MD, PhD AMA J Ethics. 2022;E233-238. doi: 10.1001/amajethics.2022.233. Pagination First page « First Previous page ‹ Previous … Page 9 Page 10 Page 11 Page 12 Current page 13 Page 14 Page 15 Page 16 Page 17 … Next page Next › Last page Last »
Podcast May 2022 Author Interview: “Seven Points for Athletes to Consider Before Using a Dietary Supplement” Dr Amy B. Cadwallader joins Ethics Talk to discuss her article: “Seven Points for Athletes to Consider Before Using a Dietary Supplement.”
Case and Commentary May 2022 ¿Cómo deberían responder los médicos al interés de los pacientes sobre suplementos dietético para tratar enfermedades crónicas graves? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES AMA J Ethics. 2022;E361-367. doi: 10.1001/amajethics.2022.361.
Health Law May 2022 ¿La regulación de suplementos dietéticos como alimentos promueve la seguridad pública en un mundo de influentes en redes sociales? Joshua Klein and Scott J. Schweikart, JD, MBE Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary can have clinical and public health consequences. AMA J Ethics. 2022;E396-401. doi: 10.1001/amajethics.2022.396.
In the Literature Oct 2002 Should Clinician-Researchers Disclose Financial Incentives to Patients? Jeremy Spevick Virtual Mentor. 2002;4(10):299-301. doi: 10.1001/virtualmentor.2002.4.10.jdsc1-0210.
Viewpoint Mar 2016 Undocumented Immigrants Face a Unique Set of Risks from Tuberculosis Treatment: Is This Just? Kelly A. Kyanko, MD, MHS, Jun-Chieh James Tsay, MD, MSc, Katherine Yun, MD, MHS, and Brendan Parent, JD Undocumented immigrants treated with isoniazid (INH) for latent tuberculosis infection should be covered for transplant for INH-related liver failure. AMA J Ethics. 2016;18(3):311-318. doi: 10.1001/journalofethics.2016.18.3.sect1-1603.
Case and Commentary Aug 2022 When Experiencing Inequitable Health Care Is a Patient’s Norm, How Should Iatrogenic Harm Be Considered? Bantale Ayisire, MS, RN and Kristen R. Choi, PhD, RN Inequitable care and outcomes experienced by persons with mental illness have long been exacerbated by stigma expressed by clinicians. AMA J Ethics. 2022;24(8):E729-734. doi: 10.1001/amajethics.2022.729.
Case and Commentary Aug 2022 When Is Iatrogenic Harm Negligent? Ramya Sampath All harm resulting from negligence is iatrogenic, but not all iatrogenic injury is negligent. AMA J Ethics. 2022;24(8):E735-739. doi: 10.1001/amajethics.2022.735.
State of the Art and Science Aug 2022 What Should Clinicians and Patients Know About the Clinical Gaze, Disability, and Iatrogenic Harm When Making Decisions? Chloë G. K. Atkins, PhD and Sunit Das, MD, PhD Avoiding harm requires that clinicians not overly rely on assumptions about “normal” embodiment. AMA J Ethics. 2022;24(8):E762-767. doi: 10.1001/amajethics.2022.762.
AMA Code Says Nov 2002 AMA Code of Medical Ethics’ Serves as "Gold Standard" Audiey Kao, MD, PhD Virtual Mentor. 2002;4(11):329-330. doi: 10.1001/virtualmentor.2002.4.11.code1-0211.
Medicine and Society Mar 2022 Por qué el acceso equitativo al parto vaginal requiere la eliminación de la medicina racial Nicholas Rubashkin, MD, PhD AMA J Ethics. 2022;E233-238. doi: 10.1001/amajethics.2022.233.